How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships

The COVID-19 pandemic has stretched the limits of pharmaceutical development and manufacturing due to the pressing need for billions of doses to reach patients as soon as possible. It is clear that broad social change, science-driven development and strong partnerships will be required to combat this public health crisis in the near term, but there will also be long term benefits from this period of accelerated innovation. During this presentation, experts from Catalent Biologics will provide an update on their partnership to enable and expedite scale-up to large-scale manufacturing, how it applies to the pandemic, and how it can be applied to future vaccine development.